EPCAM and neoplasm: However, because of tumor heterogeneity and the occurrence of epithelial-mesenchymal transition (EMT), it is common that large fractions of CTCs in various cancers exhibit low or nil expression of epithelioid markers, which remarkably compromises the clinical utility of isolation based on positive selection of EpCAM-based CTCs.